Randomized phase II study of amifostine mucosal protection by either subcutaneous injection or rapid IV bolus for patients with inoperable stage II–IIIA/B or stage IV non-small cell lung cancer with oligometastases receiving concurrent radiochemotherapy with carboplatin and paclitaxel followed by optional consolidative chemotherapy: A follow-up study after RTOG 98-01
Maria Werner-Wasik, Corey Langer, Benjamin MovsasVolume:
31
Year:
2004
Language:
english
Pages:
5
DOI:
10.1053/j.seminoncol.2004.12.012
File:
PDF, 95 KB
english, 2004